Fabrazyme for Intravenous Infusion Description:
Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme reduces globotriaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types (see CLINICAL STUDIES ).
This site is only meant for general information only. Always consult your doctor before using any medication.
|
